Clear Scientific, Inc.
3 clinical trials · Sponsor
◉ Watch Clear Scientific, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade (NCT07459166) | Clear Scientific, Inc. | 2026-05-28 |
| A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine (NCT06721494) | Clear Scientific, Inc. | 2026-02-05 |
| A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants (NCT06316973) | Clear Scientific, Inc. | 2024-02-07 |
Track Clear Scientific, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.